Literature DB >> 7952433

Intravenous cholangiography in preoperative assessment of patients considered for laparoscopic cholecystectomy.

S J Wigmore1, K Wood, J B Rainey, D A Macleod.   

Abstract

This study examines the role of intravenous cholangiography in the preoperative assessment of the first 100 patients considered for laparoscopic cholecystectomy at this institution. Intravenous cholangiography detected common bile duct (CBD) stones in 10 patients, of whom only five had a dilated CBD (> 8 mm). There were no cases of inadequate visualization of the CBD using IVC and no allergic reactions to the contrast medium. All CBD stones were confirmed by either endoscopic retrograde cholangiopancreatography (ERCP) or exploration of the CBD. There have been no cases of missed CBD stones during a follow-up period of 8 to 18 months. In contrast, ultrasound scanning was only able to detect one CBD stone, and there was a 14% incidence of inadequate visualisation of the CBD. Intravenous cholangiography is a safe, inexpensive, and highly accurate technique for assessing the CBD in patients undergoing laparoscopic cholecystectomy, with false-positive and false-negative rates of 0 in this study. The timing of the investigation permits preoperative clearance of the duct by ERCP and, should this fail, the option of a single procedure of open exploration of the CBD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952433

Source DB:  PubMed          Journal:  Surg Laparosc Endosc        ISSN: 1051-7200


  2 in total

1.  Three-dimensional reconstruction of biliary tract using spiral computed tomography for laparoscopic cholecystectomy.

Authors:  Hirohito Ichii; Moriatsu Takada; Ryoichi Kashiwagi; Masayoshi Sakane; Fumihira Tabata; Yonson Ku; Takahiro Fujimori; Yoshikazu Kuroda
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

2.  Three-dimensional drip infusion CT cholangiography in patients with suspected obstructive biliary disease: a retrospective analysis of feasibility and adverse reaction to contrast material.

Authors:  A Persson; N Dahlström; O Smedby; T B Brismar
Journal:  BMC Med Imaging       Date:  2006-04-22       Impact factor: 1.930

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.